124 related articles for article (PubMed ID: 17371231)
1. The role of class I phosphoinositide 3-kinase in T-cell function and autoimmunity.
Fruman DA
Biochem Soc Trans; 2007 Apr; 35(Pt 2):177-80. PubMed ID: 17371231
[TBL] [Abstract][Full Text] [Related]
2. Role of phosphoinositide 3-kinase signaling in autoimmunity.
Oak JS; Fruman DA
Autoimmunity; 2007 Sep; 40(6):433-41. PubMed ID: 17729037
[TBL] [Abstract][Full Text] [Related]
3. Phosphoinositide-3 kinases critically regulate the recruitment and survival of eosinophils in vivo: importance for the resolution of allergic inflammation.
Pinho V; Souza DG; Barsante MM; Hamer FP; De Freitas MS; Rossi AG; Teixeira MM
J Leukoc Biol; 2005 May; 77(5):800-10. PubMed ID: 15860799
[TBL] [Abstract][Full Text] [Related]
4. Better Understanding of Phosphoinositide 3-Kinase (PI3K) Pathways in Vasculature: Towards Precision Therapy Targeting Angiogenesis and Tumor Blood Supply.
Tsvetkov D; Shymanets A; Huang Y; Bucher K; Piekorz R; Hirsch E; Beer-Hammer S; Harteneck C; Gollasch M; Nürnberg B
Biochemistry (Mosc); 2016 Jul; 81(7):691-9. PubMed ID: 27449615
[TBL] [Abstract][Full Text] [Related]
5. PI3K in lymphocyte development, differentiation and activation.
Okkenhaug K; Vanhaesebroeck B
Nat Rev Immunol; 2003 Apr; 3(4):317-30. PubMed ID: 12669022
[TBL] [Abstract][Full Text] [Related]
6. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002.
Brunn GJ; Williams J; Sabers C; Wiederrecht G; Lawrence JC; Abraham RT
EMBO J; 1996 Oct; 15(19):5256-67. PubMed ID: 8895571
[TBL] [Abstract][Full Text] [Related]
7. Isoform-specific phosphoinositide 3-kinase inhibitors from an arylmorpholine scaffold.
Knight ZA; Chiang GG; Alaimo PJ; Kenski DM; Ho CB; Coan K; Abraham RT; Shokat KM
Bioorg Med Chem; 2004 Sep; 12(17):4749-59. PubMed ID: 15358300
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol 3-kinase facilitates bile acid-induced Ca(2+) responses in pancreatic acinar cells.
Fischer L; Gukovskaya AS; Penninger JM; Mareninova OA; Friess H; Gukovsky I; Pandol SJ
Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G875-86. PubMed ID: 17158252
[TBL] [Abstract][Full Text] [Related]
9. Frontline: The p85alpha isoform of phosphoinositide 3-kinase is essential for a subset of B cell receptor-initiated signaling responses.
Hess KL; Donahue AC; Ng KL; Moore TI; Oak J; Fruman DA
Eur J Immunol; 2004 Nov; 34(11):2968-76. PubMed ID: 15384044
[TBL] [Abstract][Full Text] [Related]
10. Selective role of PI3K delta in neutrophil inflammatory responses.
Sadhu C; Dick K; Tino WT; Staunton DE
Biochem Biophys Res Commun; 2003 Sep; 308(4):764-9. PubMed ID: 12927784
[TBL] [Abstract][Full Text] [Related]
11. Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast.
Rodríguez-Escudero I; Roelants FM; Thorner J; Nombela C; Molina M; Cid VJ
Biochem J; 2005 Sep; 390(Pt 2):613-23. PubMed ID: 15913452
[TBL] [Abstract][Full Text] [Related]
12. Activation of T cells by cross-linking Qa-2, the ped gene product, requires Fyn.
De Fazio SR; Warner CM
Am J Reprod Immunol; 2007 Oct; 58(4):315-24. PubMed ID: 17845201
[TBL] [Abstract][Full Text] [Related]
13. Differential dependence of eosinophil chemotactic responses on phosphoinositide 3-kinase (PI3K).
Mishra RK; Scaife JE; Harb Z; Gray BC; Djukanovic R; Dent G
Allergy; 2005 Sep; 60(9):1204-7. PubMed ID: 16076309
[TBL] [Abstract][Full Text] [Related]
14. Growth factor-stimulated phosphorylation of Akt and p70(S6K) is differentially inhibited by LY294002 and Wortmannin.
Adi S; Wu NY; Rosenthal SM
Endocrinology; 2001 Jan; 142(1):498-501. PubMed ID: 11145615
[TBL] [Abstract][Full Text] [Related]
15. Evidence from bioinformatics, expression and inhibition studies of phosphoinositide-3 kinase signalling in Giardia intestinalis.
Cox SS; van der Giezen M; Tarr SJ; Crompton MR; Tovar J
BMC Microbiol; 2006 May; 6():45. PubMed ID: 16707026
[TBL] [Abstract][Full Text] [Related]
16. Class IA phosphoinositide 3-kinase modulates basal lymphocyte motility in the lymph node.
Matheu MP; Deane JA; Parker I; Fruman DA; Cahalan MD
J Immunol; 2007 Aug; 179(4):2261-9. PubMed ID: 17675487
[TBL] [Abstract][Full Text] [Related]
17. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha.
Fruman DA; Snapper SB; Yballe CM; Davidson L; Yu JY; Alt FW; Cantley LC
Science; 1999 Jan; 283(5400):393-7. PubMed ID: 9888855
[TBL] [Abstract][Full Text] [Related]
18. Regulation of interleukin-5-induced beta2-integrin adhesion of human eosinophils by phosphoinositide 3-kinase.
Sano M; Leff AR; Myou S; Boetticher E; Meliton AY; Learoyd J; Lambertino AT; Munoz NM; Zhu X
Am J Respir Cell Mol Biol; 2005 Jul; 33(1):65-70. PubMed ID: 15802551
[TBL] [Abstract][Full Text] [Related]
19. T-cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling.
Deane JA; Kharas MG; Oak JS; Stiles LN; Luo J; Moore TI; Ji H; Rommel C; Cantley LC; Lane TE; Fruman DA
Blood; 2007 Apr; 109(7):2894-902. PubMed ID: 17164340
[TBL] [Abstract][Full Text] [Related]
20. Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway.
Zhang J; Choi Y; Mavromatis B; Lichtenstein A; Li W
Oncogene; 2003 Sep; 22(40):6289-95. PubMed ID: 13679867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
